Search Results - "Szidonya, Laszlo"
-
1
PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects
Published in Radiographics (01-12-2024)“…Prostate-specific membrane antigen (PSMA) radioligand therapy is an evolving treatment modality for patients with metastatic prostate cancer, offering improved…”
Get full text
Journal Article -
2
Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma
Published in Journal of neuro-oncology (01-03-2020)“…Purpose The role of maintenance immunotherapy with anti-CD20 monoclonal antibody rituximab in primary central nervous system lymphoma (PCNSL) is unclear. We…”
Get full text
Journal Article -
3
Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry
Published in Frontiers in nuclear medicine (14-12-2023)“…PSMA-targeted radiopharmaceutical therapy is an established treatment option for metastatic castration-resistant prostate cancer (mCRPC). However, response…”
Get full text
Journal Article -
4
Quantitative comparison of delayed ferumoxytol T 1 enhancement with immediate gadoteridol enhancement in high grade gliomas
Published in Magnetic resonance in medicine (01-07-2018)“…Delayed ferumoxytol enhancement on T -weighted images appears visually similar to gadoteridol enhancement. The purpose of this study was to quantitatively…”
Get full text
Journal Article -
5
Angiotensin II-Induced Expression of Brain-Derived Neurotrophic Factor in Human and Rat Adrenocortical Cells
Published in Endocrinology (Philadelphia) (01-04-2010)“…Angiotensin II (Ang II) is a major regulator of steroidogenesis in adrenocortical cells, and is also an effective inducer of cytokine and growth factor…”
Get full text
Journal Article -
6
Sec14 Homology Domain Targets p50RhoGAP to Endosomes and Provides a Link between Rab and Rho GTPases
Published in The Journal of biological chemistry (03-03-2006)“…Sec14 protein was first identified in Saccharomyces cerevisiae, where it serves as a phosphatidylinositol transfer protein that is essential for the transport…”
Get full text
Journal Article -
7
Inpatient FDG PET/CT: Point-A Strategic Path to Patient-Centered Yet Cost-Effective Care
Published in American journal of roentgenology (1976) (01-07-2024)Get more information
Journal Article -
8
Cross-inhibition of angiotensin AT1 receptors supports the concept of receptor oligomerization
Published in Neurochemistry international (01-10-2007)“…G protein-coupled receptors are cell surface receptors that mediate the effects of extracellular signals in the endocrine/paracrine and sensory systems…”
Get full text
Conference Proceeding Journal Article -
9
AT1 receptor blocker-insensitive mutant AT1A angiotensin receptors reveal the presence of G protein-independent signaling in C9 cells
Published in Biochemical pharmacology (15-05-2007)“…Although mutant receptors are highly useful to dissect the signal transduction pathways of receptors, they are difficult to study in physiological target…”
Get full text
Journal Article -
10
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions
Published in Journal of endocrinology (01-03-2008)“…Dimerization or oligomerization of G-protein-coupled receptors (GPCRs) is a novel concept, which may lead to the reevaluation of the actions of pharmacological…”
Get full text
Journal Article -
11
Cerebral Amyloid Angiopathy
Published in The Radiologic clinics of North America (01-05-2023)“…Cerebral amyloid angiopathy (CAA) is associated with deposition of amyloid proteins within the intracranial vessels. It is most frequently sporadic and risk…”
Get full text
Journal Article -
12
Quantitative comparison of delayed ferumoxytol T1 enhancement with immediate gadoteridol enhancement in high grade gliomas
Published in Magnetic resonance in medicine (01-07-2018)“…Purpose Delayed ferumoxytol enhancement on T1‐weighted images appears visually similar to gadoteridol enhancement. The purpose of this study was to…”
Get full text
Journal Article -
13
Pre-treatment immune biomarkers of pembrolizumab efficacy in patients with glioblastoma treated with standard of care
Published in Journal of clinical oncology (01-06-2024)“…2078 Background: Immune checkpoint inhibition with pembrolizumab has shown clinical benefits in multiple cancer types. However, success with checkpoint…”
Get full text
Journal Article -
14
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging
Published in Kidney international (01-07-2017)“…Contrast-enhanced magnetic resonance imaging is a commonly used diagnostic tool. Compared with standard gadolinium-based contrast agents, ferumoxytol…”
Get more information
Journal Article -
15
-
16
Molecular and Anatomic Imaging of Neuroendocrine Tumors
Published in Surgical oncology clinics of North America (01-10-2022)“…Positron emission tomography (PET) with somatostatin receptor (SSTR) ligands has taken the lead in the imaging of neuroendocrine tumors (NETs). In this…”
Get full text
Journal Article -
17
Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT1 Angiotensin and Other Gq/11 Protein-coupled Receptors
Published in The Journal of biological chemistry (19-06-2009)“…Intracellular signaling systems of G protein-coupled receptors are well established, but their role in paracrine regulation of adjacent cells is generally…”
Get full text
Journal Article -
18
Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma
Published in Leukemia & lymphoma (28-01-2019)Get full text
Journal Article -
19
Ferumoxytol-Enhanced MRI in Brain Tumor Imaging
Published in Advances in clinical radiology (Online) (01-09-2024)“…Ferumoxytol-enhanced MRI is an emerging tool in brain tumor imaging that can be used to evaluate the anatomy, vascularity, and perfusion of tumors but, most…”
Get full text
Journal Article -
20
Visualisation of normal and abnormal brain vasculature with different ferumoxytol doses
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e13517 Background: Ferumoxytol is an iron oxide nanoparticle, marketed for iron replacement therapy. Off label use as an MRI contrast agent…”
Get full text
Journal Article